Drug Information

Drug General Information
Drug ID
D06BGU
Former ID
DNC009200
Drug Name
(+/-)-3-(but-3-enyl)-1-pent-4-enoylazetidin-2-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529529]
Formula
C12H17NO2
Canonical SMILES
C=CCCC1CN(C1=O)C(=O)CCC=C
InChI
1S/C12H17NO2/c1-3-5-7-10-9-13(12(10)15)11(14)8-6-4-2/h3-4,10H,1-2,5-9H2
InChIKey
GINOGVHXZZDXCD-UHFFFAOYSA-N
PubChem Compound ID
44560666
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529529]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529529Bioorg Med Chem Lett. 2008 Jul 15;18(14):4163-7. Epub 2008 May 24.3-Alkenyl-2-azetidinones as fatty acid amide hydrolase inhibitors.
Ref 529529Bioorg Med Chem Lett. 2008 Jul 15;18(14):4163-7. Epub 2008 May 24.3-Alkenyl-2-azetidinones as fatty acid amide hydrolase inhibitors.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.